Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies

PURPOSE: There is currently no standard chemotherapy regimen for patients with lymphoid malignancies being considered for reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation (RIC-alloHSCT). The ideal regimen would provide disease control and result in lymphocyte depleti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Salit, Rachel B., Fowler, Daniel H., Wilson, Wyndham H., Dean, Robert M., Pavletic, Steven Z., Dunleavy, Kieron, Hakim, Frances, Fry, Terry J., Steinberg, Seth M., Hughes, Thomas E., Odom, Jeanne, Bryant, Kelly, Gress, Ronald E., Bishop, Michael R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2012
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295571/
https://ncbi.nlm.nih.gov/pubmed/22312100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0296
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi